https://doi.org/10.1186/s12876-022-02180-6
C
Chaoran Zang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
24
Papers
265
Citations
6
h-index
6
i10-index
Chaoran Zang is an academic researcher from Capital Medical University. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Liver Disease Diagnosis and Treatment & Cancer Immunotherapy and Biomarkers. The author has an h-index of 6, co-authored 21 publications.
ORCID: 0000-0002-2425-7156Papers by this author
worksThe monocyte to lymphocyte ratio not only at baseline but also at relapse predicts poor outcomes in patients with hepatocellular carcinoma receiving locoregional therapy
2022 · BMC Gastroenterology · 33 citations
Distinct tumour antigen-specific T-cell immune response profiles at different hepatocellular carcinoma stages
2021 · BMC Cancer · 13 citations
https://doi.org/10.1186/s12885-021-08720-9
Variations in dynamic tumor-associated antigen-specific T cell responses correlate with HCC recurrence after thermal ablation
2022 · Frontiers in Immunology · 5 citations
https://doi.org/10.3389/fimmu.2022.982578
Reprogramming of lipid metabolism in hepatocellular carcinoma resulting in downregulation of phosphatidylcholines used as potential markers for diagnosis and prediction
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.24092459
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat